Overview of the VIP2 study (POETICS2 in UK)
VIP2 stands for Very old Intensive Care Patients study 2.
An ESICM supported study conducted from the HSRO & NAHP section in ESICM.
Follow the VIP2-project on ResearchGate.
The VIP2-study was called the POETICS2 study in Great Britain.
This study sought to develop a prognostic score for specifically very old, critically ill patients defined as patients ≥ 80 years). This was a large, prospective, multinational, multicentre study. We gathered age-specific information about the elderly patient: frailty (Clinical Frailty Scale), cognitive function (IQCODE), activity of daily life (KATZ ADL) and co-morbidity, in addition to organ failure score (SOFA). Outcomes were registered as outcome at 30 days (alive or dead) and 6 months in a sub-study. Also, an Frailty score interrater variability was recorded in a sub-study.
The goal was to recruit 20 consecutive ICU patients ≥ 80 years.
3920 patients were recruited from 242 ICUs in 22 countries.
The first paper has been published.
See the list of publications.